| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 16, 2005
From the Greenberg Division of Cardiology, Weill Medical College of Cornell University, New York, NY (P.M.O., R.B.D.); Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland (M.S.N., L.O., M.V., L.T.); Sahlgrenska University Hospital/Östra, Göteborg, Sweden (S.J., B.D.); and Ulleval University Hospital, Oslo, Norway, and University of Michigan Medical Center, Ann Arbor (S.E.K.). * To whom correspondence should be addressed. E-mail: pokin{at}med.cornell.edu.
Background--The ECG strain pattern of ST depression and T-wave inversion is strongly associated with left ventricular hypertrophy (LVH) independently of coronary heart disease and with an increased risk of cardiovascular morbidity and mortality in hypertensive patients. However, whether ECG strain is an independent predictor of new-onset congestive heart failure (CHF) in the setting of aggressive antihypertensive therapy in unclear. Methods and Results--The relationship of ECG strain at study baseline to the development of CHF was examined in 8696 patients with no history of CHF who were enrolled in the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. All patients had ECG LVH by Cornell product and/or Sokolow-Lyon voltage criteria on a screening ECG, were treated in a blinded manner with atenolol- or losartan-based regimens, and were followed up for a mean of 4.7±1.1 years. Strain was defined as a downsloping convex ST segment with inverted asymmetrical T-wave opposite the QRS axis in lead V5 or V6. ECG strain was present in 923 patients (10.6%), and new-onset CHF occurred in 265 patients (3.0%), 26 of whom had a CHF-related death. Compared with patients who did not develop CHF, hypertensive patients who developed CHF were older; were more likely to be black, current smokers, and diabetic; were more like to have a history of myocardial infarction, ischemic heart disease, stroke, or peripheral vascular disease; and had greater baseline severity of LVH by Cornell product and Sokolow-Lyon voltage, higher baseline body mass indexes, higher serum glucose levels and albuminuria, similar baseline systolic and diastolic pressures, and reductions in diastolic pressure with treatment but greater reductions in systolic pressure. In univariate Cox analyses, ECG strain was a significant predictor of new-onset CHF (hazard ratio [HR], 3.27; 95% CI, 2.49 to 4.29) and CHF mortality (HR, 4.74; 95% CI, 2.11 to 10.64). In Cox multivariable analyses adjusting for baseline differences between patients with and without new-onset CHF, in-treatment differences in systolic and diastolic pressures, Sokolow-Lyon voltage, and Cornell product, and the impact of treatment with losartan versus atenolol on outcomes, ECG strain remained a significant predictor of incident CHF (HR, 1.80; 95% CI, 1.30 to 2.48) and CHF-related death (HR, 2.78; 95% CI, 1.02 to 7.63). Conclusions--ECG strain identifies hypertensive patients at increased risk of developing CHF and dying as a result of CHF, even in the setting of aggressive blood pressure lowering.
Revised on October 25, 2005
Accepted on October 31, 2005
Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
Peter M. Okin MD*,
Related Article:
Circulation 2006 113: 1.
This article has been cited by other articles:
![]() |
V. Krane, F. Heinrich, M. Meesmann, M. Olschewski, J. Lilienthal, C. Angermann, S. Stork, J. Bauersachs, C. Wanner, S. Frantz, et al. Electrocardiography and Outcome in Patients with Diabetes Mellitus on Maintenance Hemodialysis Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 394 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strand, S.E. Kjeldsen, H. Gudmundsdottir, I. Os, G. Smith, and R. Bjornerheim Tissue Doppler imaging describes diastolic function in men prone to develop hypertension over twenty years Eur J Echocardiogr, January 1, 2008; 9(1): 34 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, L. H. Lindholm, B. Dahlof, and for the LIFE Study Investigators In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study Hypertension, November 1, 2007; 50(5): 984 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, B. Dahlof, and for the LIFE Study Investigators Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients Ann Intern Med, September 4, 2007; 147(5): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mihaljevic, B.-K. Lam, J. Rajeswaran, M. Takagaki, M. S. Lauer, A. M. Gillinov, E. H. Blackstone, and B. W. Lytle Impact of Mitral Valve Annuloplasty Combined With Revascularization in Patients With Functional Ischemic Mitral Regurgitation J. Am. Coll. Cardiol., June 5, 2007; 49(22): 2191 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Lehmann Prolonged QTc Interval and Sudden Cardiac Death in Older Adults J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1473 - 1474. [Full Text] [PDF] |
||||
![]() |
S. Stern Electrocardiogram: Still the Cardiologist's Best Friend Circulation, May 16, 2006; 113(19): e753 - e756. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |